Published in Neoplasma on January 01, 1978
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients. Ann Oncol (2010) 1.14
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study. Neoplasma (2005) 0.94
The cancerostatic effects of some isothiocyanates on nitrogen mustard-sensitive and -resistant lines of Yoshida sarcoma. Neoplasma (1968) 0.90
Acute development of low T3 syndrome and changes in pituitary-adrenocortical function after elective cholecystectomy in women: some differences between young and elderly patients. Scand J Clin Lab Invest (1992) 0.84
Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour. Neoplasma (1969) 0.83
Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG). Med Oncol Tumor Pharmacother (1990) 0.80
Immunosuppression with cyclophosphamide: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production. Neoplasma (1972) 0.80
Ciprofloxacin plus vancomycin versus ceftazidime plus gentamicin in the treatment of pneumonia in granulocytopenic patients with or without venous catheters. Short communication. Chemotherapy (1992) 0.80
Adjuvant clodronate therapy in patients with locally advanced breast cancer--long term results of a double blind randomized trial. Slovak Clodronate Collaborative Group. Neoplasma (2000) 0.79
Preparation, properties and antileukemic activity of arabinosylcytosine polysaccharide conjugates. Int J Biochem (1990) 0.79
Gemcitabine and carboplatin treatment in patients with relapsing ovarian cancer. Neoplasma (2009) 0.79
Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study. Neoplasma (2005) 0.78
Therapy of P388 leukemia with benzaldehyde. Neoplasma (1988) 0.78
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study. Neoplasma (2007) 0.78
Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patients. Chemotherapy (1992) 0.77
DNA breakage and inactivation resulting from hydroxylamine and/or cis-diamminedichloroplatinum(II) interactions with plasmid DNA. Int J Biochem (1993) 0.76
Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients. Chemotherapy (1991) 0.75
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study. Support Care Cancer (2005) 0.75
Mitochondrial ATPase of Zajdela hepatoma. II. Mitochondria of Zajdela hepatoma contain less adenosine triphosphatase than mitochondria of rat liver. Neoplasma (1977) 0.75
The effect of 5-fluorouracil, ethidium bromide and chloramphenicol on some mitochondrial functions in regenerating rat liver. Neoplasma (1974) 0.75
[Trends in oncologic research]. Cas Lek Cesk (1986) 0.75
Antitumor activity and cross-resistance studies with Pt-ascorbato complexes. Neoplasma (1989) 0.75
Some properties of coupled hepatoma mitochondria exhibiting uncoupler-insensitive ATPase activity. Biochem Biophys Res Commun (1973) 0.75
[Circadian rhythm of some metabolic reactions in rats]. Fysiatr Revmatol Vestn (1971) 0.75
[Effect of adaptation to high mountain environment on the level of ninhydrine-positive compounds in urine]. Fysiatr Revmatol Vestn (1973) 0.75
[Effect of carbon dioxide baths on the metabolic adaptation of the heart muscle and the liver. 2. Changes in nucleic acids in reaction to stress]. Z Physiother (1972) 0.75
To the problem of maintenance therapy of psychopathological symptoms in temporal epilepsy. Act Nerv Super (Praha) (1973) 0.75
[Changes in biologically active material after carbon dioxide baths]. Arch Phys Ther (Leipz) (1971) 0.75
Histocompatible leukocyte transfusion during granulocytopenia. Neoplasma (1971) 0.75
[Effect of carbon dioxide baths on the metabolic adaptation of the heart muscle and the liver. 1. Changes in free and esterified fatty acids in reaction to stress]. Z Physiother (1972) 0.75
Effect of combined chemotherapy tested in partially hepatectomized rats bearing Zajdela hepatoma. Neoplasma (1983) 0.75
[Metabolism of heart muscle and liver under conditions of a pathogenic diet and in response to stress]. Cas Lek Cesk (1971) 0.75
[Effect of different thermic stimuli on the level of ninhydrine positive compounds in human blood serum]. Fysiatr Revmatol Vestn (1973) 0.75
Heterogeneity of tumor cells. Antibiot Chemother (1971) (1980) 0.75
Accelerated appearance of an ascitic tumour after long-term application of interferon to NZB/W mice. Acta Virol (1981) 0.75
Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP). Neoplasma (1990) 0.75
[Effect of adaptation to water and carbon dioxide baths and high mountain exposure on metabolic manifestations of the heart and liver. Reaction to toxic load of tetrachlormethane]. Fysiatr Revmatol Vestn (1973) 0.75
[Changes in zinc and copper levels of the blood and organs after chronic stress immobilization in rats of various ages]. Cas Lek Cesk (1986) 0.75
Blastic crisis of chronic myelogenous leukaemia. Neoplasma (1969) 0.75
Mitochondrial ATPase of Zajdela hepatoma. Presence of F1-specific antigenic determinants outside mitochondria. FEBS Lett (1978) 0.75
[Changes in metabolism in adipose tissue during stress in animals of various ages]. Bratisl Lek Listy (1982) 0.75
[Comparative study on x-ray and scintigraphie pictures and blood gases in sarcoidosis (author's transl)]. Z Erkr Atmungsorgane (1977) 0.75
Immunosuppression with thyminalkylamine (Ypenyl Spofa): effect on antibody plaque-forming spleen cells. Neoplasma (1972) 0.75
[Studies of adrenal cortex function in chronic bronchitis under climate therapy in medium and high altitude mountains of Slovakia]. Z Gesamte Inn Med (1966) 0.75
[Some properties of the new antimetabolite--3-oxauracil (author's transl)]. Bratisl Lek Listy (1978) 0.75
Comparison of some biochemical parameters of arabinosylcytosine and cyclocytidine in L1210 murine leukemia cells. Neoplasma (1990) 0.75
Biotransformation and in vitro activity of an arabinosylcytosine 5'-chloro-5'-deoxy analog. Anticancer Drugs (1991) 0.75
Drug resistance induction and cross-resistance studies with Pt-complexes. Neoplasma (1984) 0.75
The disposition of new arabinosylcytosine derivative-- 5'-chloro-5'-deoxy-arabinosylcytosine--in rats. Gen Pharmacol (1995) 0.75
[Content of ninhydrin-positive substances (amino acids and peptides) in the non-protein extract from the heart and muscles of rats during metabolic load of cardiopathogenic diet]. Cas Lek Cesk (1969) 0.75
[Effect of metabolic adaptation in the rat heart and muscle on hyperthermal stress in the water bath]. Fysiatr Revmatol Vestn (1970) 0.75
[Effect of acclimatization in the high-mountain environment on the levels of ninhydrin-positive compounds in the heart, liver and brain in rats (author's transl)]. Fysiatr Revmatol Vestn (1974) 0.75
[The development and contribution of experimental oncology to clinical practice]. Cas Lek Cesk (1988) 0.75
ADP, ATP translocator protein of rat heart, liver and hepatoma mitochondria exhibits immunological cross-reactivity. FEBS Lett (1978) 0.75
[Influence of stress on the activity of cholinesterase in the heart and liver in a 24-hour rhythm]. Fysiatr Revmatol Vestn (1976) 0.75
Different inhibitory effect of nitrogen mustard (HN2) and TS-160 (HN3) on choline transport in L 5178Y lymphoblasts. Neoplasma (1975) 0.75
[Fractures from exhaustion (author's transl)]. Bratisl Lek Listy (1979) 0.75
[Solving the complex problem of malignant neoplasms in nations belonging to the Council of Economic Mutual Aid from 1976 to 1980]. Cas Lek Cesk (1981) 0.75
Single versus combination chemotherapy of L1210 leukemia. Neoplasma (1980) 0.75
[The prognosis for cancer research and the campaign against cancer in countries belonging to the Council for Mutual Economic Assistance to the year 2000]. Cas Lek Cesk (1982) 0.75
Potentiation of cis-DDP and pyridoxal effect on isolated DNA during simultaneous application. Neoplasma (1993) 0.75
Mitochondrial ATPase of Zajdela hepatoma. V. Mitochondria of Zajdela hepatoma contain membrane sectors of ATPase complex unassociated with F1. Neoplasma (1978) 0.75
In vivo and in vitro effectivity of some platinum complexes. Neoplasma (1984) 0.75
Formation, size, and solubility in chloroform/methanol of products of protein synthesis in isolated mitochondria of rat liver and Zajdela hepatoma. Eur J Biochem (1975) 0.75
Effect of arabinosylcytosine derivative cyclocytidine on hepatal functions in rats and on Zajdela hepatoma. Gen Pharmacol (1994) 0.75
[Metabolic reactivity of the heart muscle and liver to stress following adaptation and acclimatization]. Fysiatr Revmatol Vestn (1977) 0.75
[Hyperthermal mineral bath and function of the adrenal cortex]. Arch Phys Ther (Leipz) (1966) 0.75
Antitumor activity of four polymer bound trans-1,2-diaminocyclohexaneplatinum(II)-4-carboxyphtalate complexes tested in different model systems. Neoplasma (1986) 0.75
Clastogenicity and sister chromatid exchange induction by ftorafur. Neoplasma (1981) 0.75
[The effect of dynamic stimulation of prolactin with chlorpromazine on serum zinc levels in aged people]. Vnitr Lek (1988) 0.75
Comparison of the effectivity of two diaminocyclohexane Pt-complexes. Neoplasma (1985) 0.75
[Influence of high altitude adaptation on the metabolic response following administration of adrenocorticotropic hormone and after hypoxia load in the altitude of 6000 m above sea level]. Fysiatr Revmatol Vestn (1974) 0.75
The value of the short term predictive assay in the inductive treatment of patients with acute nonlymphoblastic leukemia. Neoplasma (1986) 0.75
[Content of ninhydrin-positive substances (amino acids and peptides) in the protein free extract of the heart and muscle of rats during metabolic load with a cardiopathogenic diet. Effect of iodine in water bath]. Cas Lek Cesk (1971) 0.75
Stimulation of rat liver regeneration by chloramphenicol. Neoplasma (1975) 0.75
[Comparative study of values of blood gases and pH with gammagrams of the lungs in chronic obstructive pulmonary diseases (author's transl)]. Bratisl Lek Listy (1977) 0.75
Mitochondrial adenosine triphosphatase of Zajdela hepatoma. III. Effect of uncouplers on the hydrolysis of intramitochondrial ATP. Neoplasma (1977) 0.75
Treatment of the blastic phase of chronic myeloid leukaemia. A question to solve. Haematologica (1972) 0.75
Evaluation of synergism of drugs cis-diamminedichloroplatinum (II) and arabinosylcytosine on the level of chemical interaction with DNA and on the growth of mouse leukemia. Gen Pharmacol (1991) 0.75
Alteration of SRBC immunogenicity by cytostatics (Ypenyl and Cytembena). Neoplasma (1973) 0.75
Treatment of leukemia L1210 and P388 by arabinosylcytosine-polysaccharide conjugates. Int J Cancer (1991) 0.75
Immunosuppression with Cytembena: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production. Neoplasma (1973) 0.75
Inhibition of colony-forming cells from bone marrow of leukemic patients by 3-oxauracil. Neoplasma (1981) 0.75
Proliferation rate--drug sensitivity relation in clones isolated from heterogeneic tumor cell population. Neoplasma (1980) 0.75
Effect of "3-oxauracil" (2,3-dihydro-1,3-6H-oxazine-dione) in L1210 leukemia. Neoplasma (1977) 0.75